Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis

Glioblastoma (GBM) is a refractory disease with a poor prognosis and various methods, including maximum resection and immunotherapy, have been tested to improve outcomes. In this retrospective study we analyzed the prognostic factors of 277 newly diagnosed GBM patients over 11 years of consecutive c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Neurol
Autori principali: Ishikawa, Eiichi, Sugii, Narushi, Matsuda, Masahide, Kohzuki, Hidehiro, Tsurubuchi, Takao, Akutsu, Hiroyoshi, Takano, Shingo, Mizumoto, Masashi, Sakurai, Hideyuki, Matsumura, Akira
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287820/
https://ncbi.nlm.nih.gov/pubmed/34281518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02318-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi